Crescent Biopharma
€12.4
0
+€3+31.91% Monday 06:05
Statistics
Day High
12.4
Day Low
12.4
52W High
24.7
52W Low
6.7
Volume
-
Avg. Volume
-
Mkt Cap
1.19B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30AprExpected
Expected EPS
-0.75806620164
Actual EPS
N/A
Financials
11.39%Profit Margin
Profitable200.7MRevenue
22.86MNet Income
Analyst Ratings
$21.63Average Price Target
The highest estimate is 26.56.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow C68.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Novartis
NVS
Mkt Cap237.61B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Sarepta Therapeutics
SRPT
Mkt Cap2.51B
AMGEN
AMGN
Mkt Cap160.66B
About
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
Show more...
CEO
Mr. Joshua T. Brumm
Employees
44
Country
DE
ISIN
KYG2545C1042
WKN
000A41BDZ
Listings
0 Comments
Share your thoughts
FAQ
What is Crescent Biopharma stock price today?▼
The current price of C68.F is €12.4 EUR — it has increased by +31.91% in the past 24 hours. Watch Crescent Biopharma stock price performance more closely on the chart.
What is Crescent Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Crescent Biopharma stocks are traded under the ticker C68.F.
Is Crescent Biopharma stock price growing?▼
C68.F stock has risen by +31.91% compared to the previous week, the month change is a +29.84% rise, over the last year Crescent Biopharma has showed a -31.34% decrease.
What is Crescent Biopharma market cap?▼
Today Crescent Biopharma has the market capitalization of 1.19B
When is the next Crescent Biopharma earnings date?▼
Crescent Biopharma is going to release the next earnings report on April 30, 2026.
What were Crescent Biopharma earnings last quarter?▼
C68.F earnings for the last quarter are -3.4 EUR per share, whereas the estimation was -2.09 EUR resulting in a -62.25% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Crescent Biopharma revenue for the last year?▼
Crescent Biopharma revenue for the last year amounts to 200.7M EUR.
What is Crescent Biopharma net income for the last year?▼
C68.F net income for the last year is 22.86M EUR.
How many employees does Crescent Biopharma have?▼
As of April 02, 2026, the company has 44 employees.
When did Crescent Biopharma complete a stock split?▼
The last stock split for Crescent Biopharma was on June 16, 2025 with a ratio of 1:100.
Where is Crescent Biopharma headquartered?▼
Crescent Biopharma is headquartered in Waltham, DE.